Hints and tips:
Related Special Reports
...Leqembi, priced at $26,500 a year, was the first drug with a black-box warning — the most severe designation about possible side effects — to be granted full approval by the US Food and Drug Administration...
...J&J’s medtech division has outstripped the growth of the company’s drugs and diagnostics business, generating $30.4bn in sales last year, or 35 per cent of group revenues....
...The drug is not yet approved in the US or Europe....
...Morgan & Morgan, a personal injury law firm, on Wednesday said it had filed a case on behalf of a 44-year-old woman from Louisiana who suffered such severe vomiting after taking the drugs Ozempic and Mounjaro...
...Sixteen red states including Texas, Louisiana and Florida also last month sued the federal government over its decision to freeze approvals for new export terminals for liquefied natural gas along the US...
...But he has failed to repeat that performance at Tellurian, which floundered in its push to develop its $25bn Driftwood export project in Louisiana....
...Molnupiravir, marketed by Merck and co-developed with US biotech group Ridgeback Biotherapeutics, works by inducing small mutations in the virus itself....
...The US Food and Drug Administration in late 2021 gave a severely restricted emergency approval, making it a treatment available to those for whom other drugs were not recommended....
...MSD helped transform cancer care with its drug Keytruda, which harnessed the immune system to tackle tumours....
...More drugs will be added to the list for government negotiations....
...A set of aggressive Wall Street firms including Apollo Global Management struck a co-operative debt restructuring with Carvana, convinced that the company was turning the corner to a more sustainable trajectory...
...In the UK, Eisai submitted the drug for approval in May....
...A US cost watchdog last year suggested the annual price of semaglutide (Novo Nordisk’s Wegovy) might need to be cut to between $7,500 and $9,700, roughly half its wholesale cost....
...Elliott later made wholesale management change the focus of its demands. Since mid-May, NRG’s shares have risen 47 per cent, compared with a 10 per cent loss for the S&P 500 utilities index....
...Merck’s lawsuit is the first by a major drug company, but analysts predict others are likely to follow its lead and sue the government ahead of the full implementation of the drug price negotiation elements...
...One good read Thoughts on drug decriminalisation from a tolerant but mildly grouchy New Yorker....
...Another, more intriguing factor: the chief executive of Walmart said that new injectable diet drugs were having a small but noticeable negative impact on grocery purchases....
...The US Food and Drug Administration in January approved lecanemab, a drug co-developed by Japanese drugmaker Eisai and US biotech Biogen, under an accelerated process....
...miles across the US, including 925 miles in Louisiana, Texas and Mississippi....
...As part of the deal, Disney will allow pay-television provider Charter to offer some of its ad-supported streaming offerings — including Disney+ and ESPN+ — to its customers as part of a “wholesale” arrangement...
...The Cancer Research charity warned the UK was missing out on a “golden age” of drug discovery....
...News round-up UAE planned to use COP28 summit for oil deals, documents show (FT) Abu Dhabi’s media record under scrutiny after Telegraph deal offer (FT) Bayer chief blames thin drug pipeline on ‘years...
...Additional reporting by Yuichi Nitta, Takumi Kobayashi and Thompson Chau A version of this article was first published by Nikkei Asia on November 29. ©2023 Nikkei Inc. All rights reserved....
...“The standard and correct paths don’t work any more,” the co-founder said. “It’s very complex and feels like I’m buying drugs.”...
...Its shareholders understand that these gambles are required ahead of blockbuster drugs rolling off patent....
International Edition